Dendritic cells, indoleamine 2,3 dioxygenase and acquired immune privilege - Wikidata - wikimedia - TriplyDB

Dendritic cells, indoleamine 2,3 dioxygenase and acquired immune privilege

Dendritic cells, indoleamine 2,3 dioxygenase and acquired immune privilege

http://www.wikidata.org/entity/Q36899012

about

Targeting the indoleamine 2,3-dioxygenase pathway in cancer Anti-inflammatory therapy in chronic disease: challenges and opportunities Metabolic reprogramming and metabolic dependency in T cells Role of innate immunity against human papillomavirus (HPV) infections and effect of adjuvants in promoting specific immune response Kynurenines in the mammalian brain: when physiology meets pathology Cytosolic DNA sensing via the stimulator of interferon genes adaptor: Yin and Yang of immune responses to DNA Psychoneuroimmunology meets neuropsychopharmacology: translational implications of the impact of inflammation on behavior High-throughput sequencing reveals key genes and immune homeostatic pathways activated in myeloid dendritic cells by Porphyromonas gingivalis 381 and its fimbrial mutants.Common gamma chain cytokines promote rapid in vitro expansion of allo-specific human CD8+ suppressor T cells Halofuginone and other febrifugine derivatives inhibit prolyl-tRNA synthetase.Forced IDO1 expression in dendritic cells restores immunoregulatory signalling in autoimmune diabetes IDO2 is critical for IDO1-mediated T-cell regulation and exerts a non-redundant function in inflammation.The p50 subunit of NF-κB orchestrates dendritic cell lifespan and activation of adaptive immunity.Induction and role of indoleamine 2,3 dioxygenase in mouse models of influenza a virus infection The therapeutic potential of HDAC inhibitors in the treatment of multiple sclerosis MHC molecules in health and disease: At the cusp of a paradigm shift.Underweight full-term Indian neonates show differences in umbilical cord blood leukocyte phenotype: a cross-sectional study.The immunobiology of the mammalian epididymis: the black box is now open!Meeting report of the first conference of the International Placenta Stem Cell Society (IPLASS).Engineering DNA nanoparticles as immunomodulatory reagents that activate regulatory T cells.Immunological and nonimmunological effects of indoleamine 2,3-dioxygenase on breast tumor growth and spontaneous metastasis formation Recent developments on immunotherapy for brain cancer.Inflammatory cytokines in depression: neurobiological mechanisms and therapeutic implications.Indoleamine 2,3-dioxygenase activity contributes to local immune suppression in the skin expressing human papillomavirus oncoprotein e7.Expression and Prognostic Value of Indoleamine 2,3-dioxygenase in Pancreatic Cancer.Multifunctional dendritic cell-targeting polymeric microparticles: engineering new vaccines for type 1 diabetes.Placental expression of indoleamine 2,3-dioxygenase.Indoleamine 2,3-dioxygenase: from catalyst to signaling function.Metabolic checkpoints in activated T cells.STING, nanoparticles, autoimmune disease and cancer: a novel paradigm for immunotherapy?Signal Transducer and Activator of Transcription 1 Plays a Pivotal Role in RET/PTC3 Oncogene-induced Expression of Indoleamine 2,3-Dioxygenase 1.Is Immune Modulation the Mechanism Underlying the Beneficial Effects of Amniotic Cells and Their Derivatives in Regenerative Medicine?Elevated interleukin-27 levels in human neonatal macrophages regulate indoleamine dioxygenase in a STAT-1 and STAT-3-dependent manner.Local gene therapy with indoleamine 2,3-dioxygenase protects against development of transplant vasculopathy in chronic kidney transplant dysfunction.Good news-bad news: the Yin and Yang of immune privilege in the eye.Pancreatic islet transplants and IDO: when starving the enemy does you good The immune diet: meeting the metabolic demands of lymphocyte activation.Immunoregulatory effects of bone marrow-derived mesenchymal stem cells in the nasal polyp microenvironment.The modulation of enzyme indoleamine 2,3-dioxygenase from dendritic cells for the treatment of type 1 diabetes mellitus.CXCR3 ligands promote expression of functional indoleamine 2,3-dioxygenase in basal cell carcinoma keratinocytes.

P2860

Q26775471-20B22C3C-5623-4CB5-A302-03F43F61263B Q26860162-37B9F187-685E-4D7C-A29F-E436D8C8418E Q26864319-1F539695-3820-4320-B2F3-2E9A666E2E47 Q26996330-A840BA02-8F53-4840-B57B-AC10985324F7 Q27003296-D82C18EF-3CC5-4F2C-8E34-9EA1D3ECBBC4 Q27022855-9D865A0E-71A7-4EB0-9182-9585DF3FEADE Q27694728-28546B0B-9E94-44B6-AE7C-CC81D8654596 Q33841965-1631C7D0-EA23-4402-9646-EB90ADCA098A Q34110557-EC3D235B-97B5-456D-9C37-791D6B099C44 Q34253805-A616B438-6133-4FFC-8D14-8C22D461270F Q34323684-8B690746-80A2-49B9-9BBB-D6ADEDA51DF7 Q34396547-AF0CF5B3-CF20-4CC9-AB68-CB51201B5C75 Q34438046-120D98EB-907E-405E-9F81-9DE89B79FABA Q34778943-FC1D15BD-15EB-45CC-8AD6-E0E2D6D1FF4C Q35016997-975F7870-0135-412B-8F5A-2CE7CCE5A354 Q35107011-6B6625BF-0826-4241-94AF-29419CC74EC6 Q35512854-CB662C28-444C-4AC3-86A4-F4B0A10D3AB0 Q35579203-26B6B32D-3DA2-4CBD-9D3C-A5A1A333DF58 Q35624272-9C7F7736-EF57-4846-AE7D-4D8FBD668837 Q35949475-35880265-ED13-4235-9101-6B529F001FDE Q35986384-1EF7FE6D-5EC0-4742-AFC6-1D35F5A157AD Q35992355-7A29884D-4A1D-4224-8CAA-E4F4994A6A2E Q37089253-548EA549-77EB-44EF-AD8B-646BA7697C0F Q37188781-A301B63B-54CB-4712-BFF0-0D9F05F65168 Q37711667-8659D6AB-8BBF-4C1C-BE07-12D9B2B2B5BC Q37820820-8C5C8A43-626A-428E-B003-0523D0594F79 Q38020356-ABF5AD86-8314-4FF9-B447-24DE4C5C370E Q38032201-2DC027ED-D56A-4A73-B431-18C3E3FAA87E Q38044664-64DD46B6-9B9A-44BF-90B7-A0B537059D31 Q38293111-D322A469-191A-4CE8-86CE-8D021EF455CD Q38725391-582B73B7-5C87-4224-A8C6-DC6CE3248718 Q39034662-98A604A6-F3D7-4679-9CED-5B1AAEF74B6B Q39727068-3A1C1681-B689-402C-B50A-D2B3EEC387E8 Q40495763-AA4CF83C-AD52-4270-8D21-82FE359209CD Q41780299-C54DE5EA-793D-4733-A7B6-3B3299BB8203 Q41889772-B997ADCB-D338-47CA-8ADB-F66D107EC80A Q41898658-B1003AC2-00A2-426A-BFBB-CF7276E326BE Q42000663-29C9B37E-A4D6-423E-87BA-AF7EF982ECCF Q42339159-BAC7C91B-C35E-410B-955D-C51059C096D9 Q42490694-2C8D6C86-2C56-47F8-8B25-AA45A652E2C1

P2860

Dendritic cells, indoleamine 2,3 dioxygenase and acquired immune privilege

http://www.wikidata.org/entity/Q36899012

description

2010 nî lūn-bûn

@nan

2010年の論文

@ja

2010年論文

@yue

2010年論文

@zh-hant

2010年論文

@zh-hk

2010年論文

@zh-mo

2010年論文

@zh-tw

2010年论文

@wuu

2010年论文

@zh

2010年论文

@zh-cn

name

Dendritic cells, indoleamine 2,3 dioxygenase and acquired immune privilege

@en

type

label

Dendritic cells, indoleamine 2,3 dioxygenase and acquired immune privilege

@en

prefLabel

Dendritic cells, indoleamine 2,3 dioxygenase and acquired immune privilege

@en

P1433

Q36899012-913E1718-7196-4647-A043-F58A5C8AD858

P1476

Q36899012-00BB2659-DC11-44E4-AEDD-D58D9B22ECD7

P2093

Q36899012-59AE1563-21D4-412D-A72F-78F07FB63A31

Q36899012-972EDFAB-DAEC-42CA-B0FA-5EEAEDA9C2C0

Q36899012-B133E079-3AAC-44D4-8E4F-F4E64803F32C

Q36899012-B5D15560-28AE-42FE-B5FB-A266E8E88705

P2860

Q36899012-058CC97B-4E2A-4459-95A5-D19EADBD7BE5

Q36899012-070A8C66-27C6-463D-9239-8E084921E446

Q36899012-09581480-2F24-4CB0-9A11-0EB0472B71B0

Q36899012-0A2FF6B9-D53D-476A-9A66-59CB500FFA78

Q36899012-0B7E8EB5-273F-42D3-9FCD-2CB9A8C1742F

Q36899012-0E2422C7-3DEB-4E0F-A796-74DA04B6DA33

Q36899012-10C0B951-E447-4301-A5DB-2893690F5660

Q36899012-1333B0B0-2B0F-48A7-A4A4-346916491B95

Q36899012-1BB7E0A8-E52A-4C1B-9FCC-4554E86578EF

Q36899012-1BE702BD-2DAE-42F3-9593-2914DDC1CA66

P304

Q36899012-A0CF0C7A-4739-4291-A290-E9D63BB07CF1

P31

Q36899012-22CE6107-64BF-4E10-A8FB-A4C6C5BCD346

P356

Q36899012-BF6A94AA-E4FA-4320-8357-FD9FC27DECB7

P433

Q36899012-DB422A41-306B-4595-84F9-5A7999D76051

P478

Q36899012-30950448-8CAB-46E7-A9FF-B0F8CEFE6F39

P577

Q36899012-8BE7F568-1FB4-4461-BD46-9AFC65A9AE3D

P5875

Q36899012-4B75B671-3E1A-4F96-A050-41C736DE1529

P698

Q36899012-765F9C1B-9039-4A0F-BB3C-A693206F5296

P932

Q36899012-7B2AEC72-2EB7-4D75-B98E-EDBB82AEA4D5

P356

08830180903349669

P1433

International Reviews of Immunology

P1476

Dendritic cells, indoleamine 2,3 dioxygenase and acquired immune privilege

@en

P2093

Andrew L Mellor

http://www.w3.org/2001/XMLSchema#string

Babak Baban

http://www.w3.org/2001/XMLSchema#string

Burles A Johnson

http://www.w3.org/2001/XMLSchema#string

Lei Huang

http://www.w3.org/2001/XMLSchema#string

P2860

Histone deacetylase inhibition modulates indoleamine 2,3-dioxygenase–dependent DC functions and regulates experimental graft-versus-host disease in mice

Characterization of an indoleamine 2,3-dioxygenase-like protein found in humans and mice

Novel tryptophan catabolic enzyme IDO2 is the preferred biochemical target of the antitumor indoleamine 2,3-dioxygenase inhibitory compound D-1-methyl-tryptophan

Prevention of allogeneic fetal rejection by tryptophan catabolism

Essential role for CD103 in the T cell-mediated regulation of experimental colitis

Crystal structure of human indoleamine 2,3-dioxygenase: catalytic mechanism of O2 incorporation by a heme-containing dioxygenase

Inhibition of T cell proliferation by macrophage tryptophan catabolism

Evidence for a tumoral immune resistance mechanism based on tryptophan degradation by indoleamine 2,3-dioxygenase

Indoleamine 2,3-dioxygenase expression is restricted to fetal trophoblast giant cells during murine gestation and is maternal genome specific

Inhibition of indoleamine 2,3-dioxygenase in dendritic cells by stereoisomers of 1-methyl-tryptophan correlates with antitumor responses

P304

133-155

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.3109/08830180903349669

http://www.w3.org/2001/XMLSchema#string

P433

2

http://www.w3.org/2001/XMLSchema#string

P478

29

http://www.w3.org/2001/XMLSchema#string

P577

2010-04-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

43022186

http://www.w3.org/2001/XMLSchema#string

P698

20367139

http://www.w3.org/2001/XMLSchema#string

P932

3671384

http://www.w3.org/2001/XMLSchema#string